Today’s stock to be analyzed is Gland Pharma Limited.
Established in Hyderabad in 1978, Gland Pharma is one of the largest and fastest-growing injectable-focused B2B companies, with a global footprint across 60 countries, including the US, Europe, Canada, Australia, India and other markets.
It has a consistent compliance track record with a range of regulatory regimes across these markets and has an extensive track record in complex injectables development, manufacturing and marketing.
Let’s analyze the company’s past, present and future.
DISCLAIMER: THE ABOVE STOCK ANALYSIS/VIEW IS ONLY FOR EDUCATIONAL PURPOSE AND DO NOT CONSIDER IT AS A BUY OR SELL ADVICE.